TY - JOUR
T1 - Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease
AU - Okazaki, Mitsuyo
AU - Usui, Shinichi
AU - Fukui, Akio
AU - Kubota, Isao
AU - Tomoike, Hitonobu
PY - 2006/11
Y1 - 2006/11
N2 - Background: Patients with coronary artery disease (CAD) are known to have several lipoprotein abnormalities. We examined plasma cholesterol concentrations of major lipoproteins and their subclasses, using a gel permeation HPLC, to establish an association between a lipoprotein subclass pattern and the presence of CAD. Methods: We performed a simple and fully automated HPLC, followed by mathematical treatment on chromatograms, for measuring cholesterol concentrations of major lipoproteins and their subclasses in 62 male patients (45 with CAD and 17 controls without CAD) who underwent cardiac catheterization. Results: For major lipoprotein classes, the patient group had a significantly (P <0.05) higher LDL-cholesterol (LDL-C) and lower HDL-cholesterol (HDL-C), but no difference in VLDL-cholesterol (VLDL-C) concentrations. For lipoprotein subclasses, the patient group had a significantly higher small VLDL-C (mean particle diameter of 31.3 nm, P <0.001), small LDL-C (23.0 nm, P <0.05), and very small LDL-C (16.7-20.7 nm, P <0.001), but a significantly lower large HDL-C (12.1 nm, P <0.001) concentrations. Combined variables of "small VLDL-C + small LDL-C + very small LDL-C - large HDL-C″ differentiated the patient from the control group more clearly than single-subclass measurements or calculated traditional lipid markers. Conclusions: These results suggest the usefulness of multiple and simultaneous subclass analysis of proatherogenic and antiatherogenic lipoproteins and indicate that HPLC and its component analysis can be used for easy detection and evaluation of abnormal distribution of lipoprotein subclasses associated with CAD.
AB - Background: Patients with coronary artery disease (CAD) are known to have several lipoprotein abnormalities. We examined plasma cholesterol concentrations of major lipoproteins and their subclasses, using a gel permeation HPLC, to establish an association between a lipoprotein subclass pattern and the presence of CAD. Methods: We performed a simple and fully automated HPLC, followed by mathematical treatment on chromatograms, for measuring cholesterol concentrations of major lipoproteins and their subclasses in 62 male patients (45 with CAD and 17 controls without CAD) who underwent cardiac catheterization. Results: For major lipoprotein classes, the patient group had a significantly (P <0.05) higher LDL-cholesterol (LDL-C) and lower HDL-cholesterol (HDL-C), but no difference in VLDL-cholesterol (VLDL-C) concentrations. For lipoprotein subclasses, the patient group had a significantly higher small VLDL-C (mean particle diameter of 31.3 nm, P <0.001), small LDL-C (23.0 nm, P <0.05), and very small LDL-C (16.7-20.7 nm, P <0.001), but a significantly lower large HDL-C (12.1 nm, P <0.001) concentrations. Combined variables of "small VLDL-C + small LDL-C + very small LDL-C - large HDL-C″ differentiated the patient from the control group more clearly than single-subclass measurements or calculated traditional lipid markers. Conclusions: These results suggest the usefulness of multiple and simultaneous subclass analysis of proatherogenic and antiatherogenic lipoproteins and indicate that HPLC and its component analysis can be used for easy detection and evaluation of abnormal distribution of lipoprotein subclasses associated with CAD.
UR - http://www.scopus.com/inward/record.url?scp=33750458353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750458353&partnerID=8YFLogxK
U2 - 10.1373/clinchem.2006.070094
DO - 10.1373/clinchem.2006.070094
M3 - Article
C2 - 16990425
AN - SCOPUS:33750458353
SN - 0009-9147
VL - 52
SP - 2049
EP - 2053
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 11
ER -